U.S. health officials have approved a new option for some women battling ovarian cancer: a drug that targets a genetic mutation seen in a subset of hard-to-treat tumors. The FDA cleared the new drug under its accelerated approval pathway, reserved for medicines with promising results that must be confirmed by additional research. If the drug’s benefits do not pan out, the FDA has the option of removing it from the market.
http://www.nbcnews.com/health/cancer/new-ovarian-cancer-drug-wins-speedy-fda-approval-n698046
